Combined oxidative phosphorylation defect type 21

Combined oxidative phosphorylation defect type 21 is a rare mitochondrial disease characterized by axial hypotonia with limb hypertonia, developmental delay, hyperlactatemia, central nervous system anomalies visible on magnetic resonance imaging (e.g. corpus callosum hypoplasia, lesions of the globus pallidus) and multiple deficiency of the mitochondrial respiratory chain complexes in muscle tissue, but not in fibroblasts or liver.

Also known as: COXPD21, TARS2 combined oxidative phosphorylation deficiency, combined oxidative phosphorylation deficiency caused by mutation in TARS2, combined oxidative phosphorylation deficiency type 21, combined oxidative phosphorylation deficiency 21

13 clinical trials for this condition and its sub-types, 0 tagged with Combined oxidative phosphorylation defect type 21 itself.